awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35285004-115CDD16-DDFE-472A-BCEB-448B6FD151F2
Q35285004-115CDD16-DDFE-472A-BCEB-448B6FD151F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285004-115CDD16-DDFE-472A-BCEB-448B6FD151F2
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy.
P2860
Q35285004-115CDD16-DDFE-472A-BCEB-448B6FD151F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35285004-115CDD16-DDFE-472A-BCEB-448B6FD151F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
003d34128db7f195f1fd2ef62c652d528cec304b
P2860
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.